Individuals with the atypical variant of BDNF (i.e., -met allele carriers) show less ability to benefit from cortical plasticity induced by tDCS and aphasia therapy (Fridriksson et al., 2018b; Kristinsson et al., 2019). The gene discussed is BDNF; the disease is Aphasia.